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Abstract
Background: The murine air pouch membrane represents an easily accessible tissue for studies on gene regulation
in acute inflammation. Considering that acute inflammation may affect expression of molecular reference genes,
we evaluated the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and prolylpeptidyl isomerase
A (PPIA) in the air pouch membrane during a complete time course of urate crystal inflammation and correlated
the results with expression of interleukin (IL)-1b and hypoxia inducible factor (HIF)-1a. In addition, we aimed to
identify alternate potential reference genes.
Methods: Using custom microfluidic real-time PCR arrays, the expression of 96 genes including GAPDH, PPIA, IL-1b,
and HIF-1a was determined in dissected air pouch membranes 1, 4, 9, 18, 27, and 50 hours (h) after injecting
monosodium urate (MSU) crystals into the pouch. One-way ANOVA was used to detect differential gene expression
throughout the time course. Using the genes on these arrays as a convenience sample, alternate candidate
reference genes were sought (1) with a biostatistical approach and (2) using the geNorm software tool.
Results: Pouch leukocytes peaked at t = 9h and declined toward t = 50h. PPIA expression was not differentially
regulated (p = 0.52, ANOVA). In contrast, GAPDH mRNA increased steadily after crystal injection, reaching a
maximal 2.8-fold increase at t = 18h (p = 0.0006, t test), which followed a marked induction of IL-1b (max., 208-fold
at t = 4h, p = 8.4 × 10
-5, t test) and HIF-1a (max., 6.6-fold at t = 4h, p = 0.00025, t test). Fifteen genes were
artifactually identified as “significantly regulated” when Ct values were normalized against GAPDH expression. The
biostatistical approach and the geNorm analysis identified overlapping sets of candidate reference genes. Both
ranked PPIA as the best candidate, followed by defender against cell death 1 (DAD1) and high-mobility group B1
(HMGB1).
Conclusions: GAPDH mRNA expression is up-regulated in urate crystal inflammation, possibly due to inflammation-
associated hypoxia. Using GAPDH mRNA for molecular normalization resulted in significant artifacts in the
calculated expression of the target mRNAs. PPIA and other stably expressed genes promise to be more appropriate
reference genes in this model.
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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and prolylpeptidyl isomerase A (PPIA) as potential
reference genes
GAPDH is often used for molecular normalization of gene
expression data from microarrays or real-time reverse
transcriptase polymerase chain reactions (qPCR). This is
based on the assumption that expression of this “house-
keeping gene” does not change much during the life cycle
of most cells and can thus be used as a relatively constant
reference signal. However, while this notion has been sub-
stantiated in some scenarios, there are clear examples that
GAPDH mRNA expression can vary (e.g., [1-3]). Notably,
hypoxia can induce GAPDH mRNA levels, likely because
binding of a complex of the inducible a subunit and the
constitutively expressed b subunit of hypoxia inducible
factor (HIF)-1 to a hypoxia response element (HRE) in the
GAPDH promoter region can increase transcription of
this gene [4-6]. Considering that hypoxia is a well docu-
mented feature of inflammatory cells and inflamed tissues
[7,8], including the synovial membrane [9], that HIF-1 can
be activated in inflammation due to toll-like receptor
(TLR) signaling [8,10], and that HIF-1a is expressed
widely in inflamed synovial membranes [11], GAPDH may
not be a suitable reference gene for molecular normaliza-
tion in gene expression studies of acute synovitis, includ-
ing crystal inflammation.
PPIA (also known as cyclophilin A) is a ubiquitously
expressed intermediate factor of calcium/calmodulin sig-
naling. Its activity is regulated predominantly at the post-
transcriptional level. While it has been validated as a use-
ful reference gene for qPCR in specific scenarios [12,13],
its transcriptional regulation has been demonstrated in
hypoxic cells [4] and in at least one example of a chroni-
cally inflamed tissue [14]. Thus, there is reason to suspect
that it, too, may be a suboptimal reference gene in studies
on inflammation.
The murine air pouch model of inflammation
The murine air pouch is a bursa-like structure that is
lined with a membrane resembling the lining of human
joints, both histologically and biochemically [15]. The
pouch lumen is an easily accessible space, and different
inflammatory processes can be elicited easily by injecting
the respective pro-inflammatory agent. The air pouch
membrane can be removed from the mouse nearly quan-
titatively by blunt dissection and thus provides an attrac-
tive system for studying inflammation-related gene
expression changes in a synovium-like tissue, while mini-
mizing transcriptional noise hailing from the adjacent
structures [16]. However, the usefulness of common
reference genes for real-time PCR analysis of this tissue
has not been examined. Considering the fulminant
inflammatory reaction that ensues after injecting the
crystals, changes in basic elements of cellular metabolism
affecting expression of otherwise stably expressed genes
appear likely. Using a time course experiment spanning
initiation, peak and resolution of inflammation in the air
pouch, we have therefore evaluated GAPDH and PPIA as
reference genes for molecular normalization in this
model. We find relatively stable expression of PPIA, but
a steady rise of GAPDH mRNA levels that peak after
maximal leukocyte accumulation in the pouch lumen,
and we speculate that inflammation-associated hypoxia
and/or oxidative stress are causative factors.
Methods
Murine air pouch model
A 50-hour time course of urate crystal inflammation was
carried out in the murine air pouch as described [16,17]
(Figure 1). Briefly, air pouches were raised on the backs
of 6-week-old female BALB/c mice by subcutaneously
injecting 3 ml sterile air and reinflating with 2 ml sterile
air on day 3. Endotoxin-free monosodium urate crystals
were synthesized according to the McCarty method [18].
Figure 1 Schematic timelines of the formation of the air pouch
(A) and the time course experiment (B). A. Three ml of filtered
air are injected under the dorsal skin. The resulting air pouch is
reinflated on day 3 with an additional injection of 2 ml. A newly
formed thin membrane lines the pouch lumen by day 6. B. Two mg
endotoxin-free MSU crystals are injected into the pouch on day 6.
At the indicated time points (x-axis), the inside of the pouch is
lavaged with PBS to determine the number of leukocytes, and the
pouch membrane is then isolated from the surrounding tissues by
blunt dissection and processed for gene expression analysis. Four
mice were used at t = 1h and t = 4h, and 3 mice at each of the
other time points.
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phosphate buffered saline was injected into 6-day-old
pouches. Mice (3-4 per time point) were killed 1, 4, 9, 18,
27, and 50 hours (h) after injecting the crystals, exudate
leukocytes were quantified with a hemocytometer, and
pouch membranes obtained by blunt dissection as
described [16]. The t = 0h membranes were obtained at
the beginning of the experiment from air pouches which
had not been injected with crystals or buffer. The study
was approved by the Institutional Animal Care and
Research Committee of the Philadelphia VA Medical
Center.
Quantitative PCR analysis
Membranes were homogenized, total RNA extracted with
RNeasy spin columns (Qiagen, Valencia, CA), and cDNA
synthesized with Superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA), following the recommenda-
tions of the manufacturers. Expression of 96 target genes
was quantified on an HT7900 Sequence Analyzer
(Applied Biosystems [ABI], Foster City, CA) using cus-
tom microfluidic Taqman PCR arrays (ABI) following the
manufacturer’s protocols (http://www.appliedbiosystems.
com). The arrays had been custom designed to contain
three reference genes (18S rRNA, PPIA, and GAPDH)
and 93 target genes relating to several functional path-
ways and processes (cell cycle, apoptosis, prostaglandin
metabolism, inflammasome components, cytokines,
defensins, matrix metalloproteinases, markers for specific
cell types, and several miscellaneous targets of interest)
to study their regulation, if any, in urate crystal inflam-
mation. While the present manuscript focuses on refer-
ence gene selection, the analysis of expression of the
functional pathways will be the subject of a separate
publication.
Pre-analytic data processing
Ten of the 96 genes on the arrays were removed from the
analysis because two or more values were missing and
this lack of detection could not be explained by a biologi-
cally plausible absence of expression at beginning or end
of the time course. A Ct of 40 was assigned for missing
values when absence of detection was likely due to phy-
siological lack of expression at beginning or end of the
time course; the mean Ct value of the time point was
used when missing values were likely due to technical
failure. All Ct values were subtracted from 40 such that
higher Ct values corresponded to higher gene expression.
To avoid the value 0 for samples with Ct = 40, the
Laplace correction (adding a pseudocount of 1 to all
values of the data set) [19] was used, thus obtaining (41-
Ct). 18S rRNA, which is routinely included on these cus-
tom PCR arrays by the manufacturer, had to be excluded
from the analysis because a batch effect was noted in
principal component analysis (results not shown), which
was due to low detection levels for this gene on three of
the arrays. The Ct values of 18S rRNA did not correlate
with mean Ct values across the arrays. Therefore, they
did not reflect low overall gene expression in the affected
samples, but were likely due to a manufacturing error.
Eighty-five of the original 96 genes thus passed the prea-
nalytic quality screen and were included in the analyses.
Statistical analyses
Differential regulation in the time course of target genes
of interest was determinedw i t ho n e - w a yA N O V Aa n d
the Kruskal-Wallis test, comparing t = 0h against the
subsequent time points. P values were adjusted for mul-
tiple testing using the Benjamini-Hochberg (BH) correc-
tion method. Similar results were obtained with the two
methods, but only p values obtained with ANOVA are
shown for the sake of simplicity. For each target, a t test
was performed between t = 0h and the time point asso-
ciated with the greatest change in expression. Variation
in gene expression was also assessed by median absolute
deviation from the median (MAD) [20]. MAD is a more
robust measure of data variability than standard devia-
tion, which is obtained by multiplying MAD by a con-
stant scaling factor. All statistical analyses were
performed using code written in the R programming
language (R project for statistical computing; http://
www.r-project.org). The software tool geNorm [21]
(available at http://www.biogazelle.com/genormplus/gen-
orm) was also used to identify potential reference genes.
It ranks a group of candidate reference genes according
to the M value, i.e. the mean of all the standard devia-
tion values between the Ct values of the gene in ques-
tion and the Ct values of each of the other potential
reference genes under consideration. A lower M value
denotes a higher rank among the candidates.
Results
Up-regulation of GAPDH, but not PPIA, mRNA in urate
crystal inflammation
Quantification of pouch exudate leukocyte counts, the
gold standard for measuring inflammation in this model,
revealed a rapid evolution of inflammation that peaked at
t = 9h and then returned to near normal by t = 50h
(Figure 2A). A dramatic surge in IL-1b mRNA level in
the membrane preceded this peak of leukocyte transmi-
gration by several hours, reaching a 208-fold increase at t
=4 h .H I F - 1 a was also up-regulated significantly (p =
0.000067, ANOVA), albeit less dramatically (maximal
increase, 6.6-fold at t = 4h, p = 0.00025, t test). Inspection
of the relative expression values of PPIA revealed an
apparent mild increase after t = 0h. Even though the
apparent difference at the maximum (t = 4h) with respect
to t = 0h approached significance (p = 0.06, t test), PPIA
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regulated significantly (p = 0.52, ANOVA) (Figure 2B). In
contrast, GAPDH mRNA levels increased 4h after crystal
injection, peaked at t = 18h, and began to decline there-
after (p = 0.023, ANOVA). The differences compared
w i t ht=0 hw e r em o s ts i g n i f i c a n ta tt=1 8 h( 2 . 8 - f o l d
change, p = 0.0006, t test). Thus, GAPDH expression was
up-regulated significantly after the peak of inflammation
in the pouch membrane. In contrast, PPIA was expressed
relatively stably.
To exclude that the rise in GAPDH mRNA merely
reflected a general induction of transcription at these
time points or systematic differences in RNA or cDNA
amount or quality, the mean Ct value across all 85 tar-
gets and samples was calculated for each time point.
This overall mean transcription peaked at t = 4h and
thus clearly followed different kinetics than regulation of
GAPDH.
Artifacts resulting from normalization against GAPDH
expression
The rise in GAPDH expression suggested that it should
not be used as a reference mRNA in this model. To
Figure 2 Expression of IL-1b,H I F - 1 a, GAPDH, and PPIA in the
air pouch membrane in a 50-hour time course of MSU crystal
inflammation. A. Leukocyte numbers were determined in lavaged
pouch exudates by manual cell counting with a hemocytometer.
Values are expressed as 1 × 10
6 leukocytes/pouch (y-axis). B.
Changes in expression of IL-1b, HIF-1a, GAPDH and PPIA relative to
t = 0h. Four mice were used at t = 1h and t = 4h, and 3 mice at
each of the other time points. For each target, the p value (t test) is
indicated at the time point of maximal fold change with respect to
t = 0h.
Figure 3 Comparison of normalization strategies. A.V e n n
diagram demonstrating differences in the populations of regulated
mRNAs that result when the Ct values from the PCR arrays were not
normalized ("None”) or normalized against PPIA or GAPDH
expression. The analysis is based on 85 of the 96 targets on the PCR
arrays which passed an initial quality screen for missing values (see
Methods). The intersecting lines define shared and distinct target
gene populations. The values refer to the number of genes
apparently regulated significantly (fold change ≥ 1.5, p < 0.05) in
the time course. The three methods identified the following
numbers of significantly regulated genes: no normalization, 62; PPIA
normalization, 60; and GAPDH normalization, 73. B. Artifactual
down-regulation of HMGB1 mRNA due to normalization against
GAPDH. Expression of HMGB1 throughout the time course was
determined in the non-normalized (violet line), GAPDH-normalized
(black line), and PPIA-normalized (red line) data sets. P values for
significance of regulation were determined with one-way ANOVA:
no normalization, 0.52; PPIA normalization, 0.074; GAPDH
normalization, 0.0037. Fold change with respect to t = 0h is plotted
on the y-axis. For each normalization condition, the p value (t test)
is indicated at the time point of maximal fold change.
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normalization to GAPDH in this data set, the number of
significantly regulated (fold change ≥ 1.5, p < 0.05 by
ANOVA with BH correction for multiple testing) target
genes was computed under three conditions: (1) without
prior normalization, (2) normalized against GAPDH, and
(3) normalized against PPIA (Figure 3A). Whereas there
was good agreement between the non-normalized and
the PPIA-normalized data sets, normalization against
GAPDH resulted in the identification of 15 unique “regu-
lated” mRNAs. To exemplify one specific artifact result-
ing from normalizing against GAPDH, the kinetics of the
expression of HMGB1, which was identified as “regu-
lated” only in the GAPDH-normalized data set, were
then plotted under each of the three normalization con-
ditions (Figure 3B). Whereas similar kinetics resulted in
the non-normalized and PPIA-normalized data sets,
GAPDH normalization led to an apparent down-regula-
tion of HMGB1 mRNA (p = 0.0037, ANOVA) which cor-
related inversely with GAPDH up-regulation. Thus, using
GAPDH as a molecular reference led to significant
changes in data interpretation in this model, whereas
PPIA-normalized values agreed better with the data
obtained from the non-normalized data set.
Identification of alternate candidate reference mRNAs
Among the 85 genes on the arrays that passed the initial
quality screen (see Methods), one-way ANOVA identified
23 genes as “not regulated” (p ≥ 0.05, after BH correction,
using the non-normalized data set). These were then
used as a convenience sample to screen for additional
candidate reference genes. Figure 4A represents, for each
target mRNA in all 23 samples,ap l o to fv a r i a t i o ni nC t
values, defined by MAD, versus the p value obtained with
one-way ANOVA. PPIA, HMGB1, and DAD1 were the
three mRNAs with the lowest MAD values (0.28, 0.32
and 0.34, respectively), and all three also had high p
values and thus constituted the best candidates.
In an independent approach, the same set of 23 non-
regulated genes was analyzed with the software program
geNorm. Thirteen genes had M values < 0.5, a generally
accepted cut-off for the identification of potentially useful
reference genes [21] (Figure 4B). Of note, this unbiased
screen identified the same top three genes as the MAD/
ANOVA approach, PPIA (M = 0.23) being the best can-
didate, followed by DAD1 (M = 0.25) and HMGB1 (M =
0.26).
To test whether combinations of these three genes
would result in further improvement in normalization,
the Ct values of the genes on the arrays were normal-
ized against the geometric mean of the Ct values of
PPIA, DAD1 and HMGB1. Compared with normalizia-
tion against PPIA alone, 4 additional regulated genes
were identified when the geometric mean of PPIA and
Figure 4 Identification of candidate reference genes. A. Median
absolute deviation from the median (MAD) of 23 genes which were
identified with ANOVA as “not regulated” (p ≥ 0.05) is plotted against
the p values determined by ANOVA. Genes possessing low MAD but
high p values (p >> 0.05) would constitute candidate reference genes.
The three genes with the lowest MAD are identified by red (PPIA),
orange (DAD1) and light blue (HMGB1) dots. The dotted line
represents the p value threshold of 0.05. B. geNorm analysis of the
same 23 genes as in A. The final output contains 22 genes since
geNorm excluded IFN-g due to excess missing values. The y-axis
represents the average expression stability (M value) of the remaining
22 genes. PPIA, DAD1 and HMGB1 have the lowest M values and
constitute the best candidate reference genes. Abbreviations: ADK,
adenosine kinase; BAD, Bcl associated death promoter; BIRC5,
baculoviral IAP repeat containing 5; CKM, creatine kinase (muscle);
CD3e, cluster of differentiation 3, ε subunit; CD1a, cluster of
differentiation 1a; CMA1, mast cell chimase; COX1, cyclooxygenase 1;
DAD1, defender against cell death 1; DMD, dystrophin; GPCR44, G-
protein coupled receptor 44; HMGB1, high mobility group B1; IL-11,
interleukin 11; MMP19, matrix metalloproteinase 19; MPO,
myeloperoxidase; NURR1, nuclear receptor related 1; PCNA,
proliferating cell nuclear antigen; PIGF, phosphatidyl inositol glycan
anchor biosynthesis, class F; PLCg1, phospholipase C g1; PPIA,
prolylpeptidyl isomerase A; SIVA1, SIVA1 apopotosis-inducing factor;
TUBB3, tubulin b3.
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three genes was used (Figure 5).
Discussion
Inutility of GAPDH as reference gene in MSU crystal
inflammation
We detected significant up-regulation of GAPDH expres-
sion in the anticlimactic phase of acute urate crystal
inflammation in this simple tissue resembling the human
synovial membrane. These results suggest strongly that
GAPDH should not be used as a reference gene in urate
crystal inflammation and, likely, similar forms of acute
inflammation driven by innate immunity. It remains to be
determined whether this also applies to chronic or less ful-
minant inflammatory processes, but caution is indicated.
In any case, these results underscore how important it is
to test for any systematic regulation of GAPDH mRNA
expression before considering it for molecular normaliza-
tion in a new experimental system.
Potential mechanisms of GAPDH induction in MSU crystal
inflammation
What might be the underlying mechanism that increased
transcription of this enzyme? The presented data are the
f i r s tr e p o r to fH I F - 1 a induction in urate crystal inflam-
mation, but the available evidence from related inflam-
matory systems allows us to speculate that the increased
GAPDH expression is due to increased HIF-1a activity.
This might result from at least two synergizing processes,
(1) higher HIF-1a protein levels due to increased stability
resulting from proline hydroxylation (which could not be
assessed in our mRNA-based analysis), and (2) increased
transcription of the HIF-1a gene within the first hours of
crystal injection (Figure 2). These changes may arise
from activation of more than one molecular pathway.
Urate crystals induce fulminant inflammation in the air
pouch that is characterized by massive induction of
innate immunity. The crystals are sensed as danger-asso-
ciated molecular patterns (DAMPS) by the NALP3
inflammasome (leading to the proteolytic processing and
release of IL-1b), and by other receptors including TLR 2
and 4 [22]. Notably, TLR 2 and 4 (as well as TLR 7 and 8,
but these are not known to be activated by urate crystals)
have been shown to activate HIF-1a activity [8,10]. This
can be seen as part of the intracellular adaptation to
hypoxic and oxidative stress that infiltrating inflamma-
tory cells are invariably exposed to. Injecting urate crys-
tals into the air pouch causes a major influx of innate
immune cells, consisting of neutrophilic granulocytes,
monocytes (which express TLR 2 and 4), and mast cells
[23] (whose activation also leads to increased HIF-1a
activity [24]), all of which ultimately results in the release
of major proinflammatory cytokines and reactive oxygen
species (ROS). Moreover, focal hypoxia is a common fea-
ture of inflamed tissues [7], including the synovial mem-
brane [9], likely due to increased oxygen demand in the
tissue in the presence of vascular congestion. A recent
report in this journal on expression of GAPDH in tumor
and non-tumor cell lines clearly demonstrated that
GAPDH expression increases under hypoxic conditions
in a cell-type specific manner [2], likely due to HIF-1a
induction. GAPDH is a key enzyme of glycolysis. A HIF-
1a-induced increase in GAPDH activity would activate
this pathway, thus improving the intracellular energy bal-
ance by providing additional ATP molecules. In addition,
intracellular ROS can induce HIF-1a activity [8]. Besides
these intracellular ROS, which serve as signaling mole-
cules in innate immune cells during activation, neutro-
phil and mast cell degranulation leads to additional
oxidative stress in the tissue, and increased GAPDH
activity may increase survival of affected cells by increas-
ing the availability of ATP and reducing equivalents.
Thus, the observed induction of GAPDH in the pre-
sented study may be explained biochemically in two, not
Figure 5 Normalization against geometric means. Venn diagram
demonstrating differences in the populations of mRNAs identified
as “regulated” when the Ct values from the PCR arrays were
normalized against PPIA alone, against the geometric mean of PPIA
and DAD1 ("Geom Mean 2”) or the geometric mean of PPIA, DAD1
and HMGB1 ("Geom Mean 3”). The analysis is based on the same 85
targets as in Figure 3A. The intersecting lines define shared and
distinct target gene populations. The values refer to the number of
genes apparently regulated significantly (fold change ≥ 1.5, p <
0.05) in the time course. The three methods identified the following
numbers of significantly regulated genes: PPIA alone, 60; Geom
Mean 2, 64; Geom Mean 3, 63.
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TLR signal transduction triggered by urate crystals and
(2) as a central feature of the tissue adaptation to hypoxia
and oxidative stress. Future studies should be directed at
testing these models experimentally.
PPIA, DAD1 and HMGB1 as potential reference genes for
urate crystal inflammation
The MAD and geNorm analyses highlighted several sta-
bly expressed genes, and both of these unbiased
approaches identified PPIA as the best candidate refer-
ence gene. PPIA has been validated for molecular nor-
malization in qPCR analysis of, for instance, colorectal
and breast cancer tissue [12,13]. It now promises to be a
useful reference gene also in urate crystal inflammation
and, possibly, similar states of inflammation. DAD1 is a
subunit of the enzyme oligosaccharyltransferase and can
counteract apoptotic cell death [25]. Interestingly, MSU
crystals inhibit neutrophil apoptosis [26]. While it is not
known whether this process involves DAD1 activity, our
results indicate that the crystals at least do not affect
transcription of the DAD1 gene. HMGB1 is a multifunc-
tional protein that usually resides in the nucleus and
functions in DNA repair [27]. But it also plays important
extracellular roles in innate immunity as an “alarmin”,
where it is released from cells through activation of the
very NALP3 inflammasome that is activated by MSU
crystals [28]. Although this has not been addressed
experimentally, induction of HMGB1 activity in response
to MSU crystal is highly likely. Its identification as a sta-
bly expressed gene in MSU crystal inflammation was,
therefore, unexpected. A likely explanation is that its
activity is regulated predominantly, if not exclusively, at
the post-transcriptional level in this type of acute but
self-limiting process.
Using the geometric mean of a combination of two or
m o r er e f e r e n c eg e n e sh a sb e c o m eac o m m o n l yr e c o m -
mended strategy for molecular normalization of RT-PCR
data sets [29]. The geNorm analysis suggested that the
combination of PPIA, DAD1 and HMGB1 would consti-
tute the optimal normalization strategy in the current data
set. Using this combination affected the number of genes
identified as “significantly regulated” in a relatively minor
way, which might be viewed as “fine tuning” of normaliza-
tion against PPIA alone. Additional changes due to using
this combination may be more subtle and, for instance,
affect the measured kinetics of some of the regulated
genes.
Limitations
This study is limited by the fact that reference genes that
are commonly used in inflammation-related gene expres-
sion studies, notably b-actin and 18S and 28S rRNA, were
not included in the analysis and that no attempt was made
to elucidate the mechanisms underlying GAPDH induc-
tion or to verify expression of the protein products of the
studied mRNAs. Moreover, DAD1 and HMGB1 and the
other stably expressed genes other than PPIA were
included on the arrays ap r i o r inot as potential reference
genes but in order to test whether their expression might
be functionally regulated in urate crystal inflammation.
However, our results do suggest that a post hoc data
mining approach of PCR arrays may be useful to screen
for additional candidate reference genes. Clearly, future
studies of urate crystal inflammation should be designed
to (1) further validate PPIA, DAD1 and HMGB1 as refer-
ence genes and to compare their performance directly
with that of commonly used reference genes and (2) to
provide more experimental evidence for the hypothetical
model of HIF-1a-associated GAPDH induction outlined
at the beginning of this section.
Conclusions
GAPDH mRNA expression is up-regulated in urate
crystal inflammation, possibly due to inflammation-asso-
ciated hypoxia and/or oxidative stress. Using GAPDH
mRNA for molecular normalization resulted in signifi-
cant artifacts in the calculated expression of the target
mRNAs, and it should therefore not be used as a refer-
ence mRNA in studies on MSU crystal inflammation.
PPIA and other stably expressed genes, including DAD1
and HMGB1, promise to be more appropriate reference
genes in this model.
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